A Phase II Trial of RAD001 in Triple Negative Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 17 Sep 2013
At a glance
- Drugs Everolimus (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 19 Apr 2012 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 19 Apr 2012 Actual initiation date changed from Jun 2009 to Apr 2009 as reported by ClinicalTrials.gov.